@article{mbs:/content/journal/acmi/10.1099/acmi.ac2020.po0508, author = "Lin, Yao-Tang and Chiweshe, Stephen and McCormick, Dominique and Gaunt, Eleanor and Simmonds, Peter and J. Wilson, Sam and Grey, Finn", title = "Identification of interferon-stimulated genes with anti-HCMV activity", journal= "Access Microbiology", year = "2020", volume = "2", number = "7A", pages = "", doi = "https://doi.org/10.1099/acmi.ac2020.po0508", url = "https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.ac2020.po0508", publisher = "Microbiology Society", issn = "2516-8290", type = "Journal Article", eid = "609", abstract = "As a first line of defence, the interferon-mediated innate immune response is pivotal to protect cells against invading pathogens. At the heart of it are hundreds of interferon-stimulated genes (ISGs) upregulated substantially shortly after viral infection. Some of these ISGs act indirectly to interfere with virus life cycle via regulation of interferon signalling pathways whereas other ISG can act directly to inhibit viral replication via interaction with viral components. Although many of the ISGs have been identified decades ago, only a handful of them have been characterized about their antiviral activity. Here, we used an arrayed expression lentivirus library of more than 400 ISGs to identify the ISGs with anti-HCMV activity. We performed parallel screens using wild type fibroblast cells and IRF3 KO fibroblast cells generated by CRISPR/Cas9 editing to identify ISGs more likely to directly inhibit HCMV, as opposed to activation of IFN signalling. The IRF3-independent ISGs identified in the screen include those that signal through IRF3 independent pathways such as IRF7 or known to inhibit HCMV directly such as IDO, RIPK2 and AIM2 validating the screening approach. Interestingly, we also identified novel IRF3-independent anti-HCMV ISGs, indicating they may play a role in directly inhibiting the virus.", }